[1] |
Delaney WE 4th. Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil.J Antimicrob Chemother, 2007, 59: 827-832.
|
[2] |
中华医学会肝病学分会. 中华医学会感染病学分会.慢性乙型肝炎防治指南(2010版). 肝脏,2011,16:2-16.
|
[3] |
Mauss S, Berger F, Filmann N, et al. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B. J Hepatol, 2011,55:1235-1240.
|
[4] |
Ha NB, Ha NB, Garcia RT, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology, 2009, 50: 727-734.
|
[5] |
赵康路,郭秋芳,叶卫江. 单用或联合使用阿德福韦酯引起尿β2-微球蛋白改变的研究. 浙江临床医学, 2016,18: 253-255.
|
[6] |
王晓今,傅青春,臧祖胜. 表现为范可尼综合征的阿德福韦酯相关慢性肾脏病15例分析. 肝脏, 2014, 19: 475-478.
|